Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Alopecia areata significantly worsens quality of life, suggesting a need for mental health support.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Alopecia areata may be linked to higher heart disease risk.

Disease-specific tools better assess quality of life in alopecia areata patients.

Mesenchymal Stem Cell Conditioned Media can significantly regrow hair in alopecia areata patients.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Azelaic acid 20% cream works well for treating scalp alopecia areata and can be an alternative to clobetasol ointment.

Higher IL-19 levels are linked to more severe Alopecia Areata.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Alopecia areata patients have worse quality of life, anxiety, and depression than vitiligo patients.

A unique type of hair loss mimics another condition but has minimal inflammation and specific immune cells present.

Eyebrow and eyelash hair loss in alopecia areata worsens quality of life.

ALUDWIG can help standardize female hair loss assessment from a single image.

Higher bad cholesterol levels are linked to more severe female pattern hair loss.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The new tool helps measure the impact of alopecia areata on children's quality of life.

Male pattern baldness in medical students is linked to higher depression, loneliness, and internet addiction.

Topical minoxidil improves life quality for women with hair loss.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Microneedling, especially with drugs, effectively treats hair loss.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Adapted classification better assesses male pattern hair loss and its link to heart disease.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Women's acne improvement with antibiotics is not linked to signs of high male hormones.

Men with enlarged prostates often have more severe baldness.